Adina Vultur Selected Research

Adina Vultur Research Topics

Disease

27	Melanoma (Melanoma, Malignant) 01/2023 - 11/2008
22	Neoplasms (Cancer) 11/2021 - 03/2002
4	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2013
2	Hypoxia (Hypoxemia) 12/2017 - 12/2013
1	Infections 07/2009
1	Hematologic Neoplasms (Hematological Malignancy) 11/2008
1	Breast Neoplasms (Breast Cancer) 05/2008
1	Philadelphia Chromosome 04/2007
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2007
1	Adenoma (Adenomas) 01/2003
1	Carcinoma (Carcinomatosis) 01/2003
1	Hyperplasia 01/2003

Drug/Important Bio-Agent (IBA)

5	Phosphotransferases (Kinase)IBA 08/2016 - 04/2007
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2021
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2010
4	VemurafenibIBA 12/2013 - 10/2010
3	src-Family KinasesIBA 11/2008 - 04/2007
2	Proto-Oncogene Proteins B-rafIBA 11/2022 - 10/2010
2	CalciumIBA 11/2022 - 01/2016
2	Therapeutic UsesIBA 01/2022 - 12/2017
2	Protein Isoforms (Isoforms)IBA 08/2016 - 12/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2013 - 12/2010
2	Adenosine Triphosphate (ATP)IBA 06/2013 - 06/2012
2	Small Interfering RNA (siRNA)IBA 01/2013 - 07/2009
2	Dasatinib (BMS 354825)FDA Link 11/2008 - 04/2007
1	AntioxidantsIBA 11/2022
1	Glycogen Synthase (Synthase I)IBA 01/2022
1	CollagenIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	mitochondrial calcium uniporterIBA 01/2018
1	azomycinIBA 12/2017
1	TH 302IBA 12/2017
1	Sunitinib (Sutent)FDA Link 12/2017
1	ProdrugsIBA 12/2017
1	Immune Checkpoint InhibitorsIBA 11/2017
1	SCH772984IBA 11/2016
1	proto-oncogene proteins pimIBA 08/2016
1	SGI 1776IBA 08/2016
1	Calcium Channels (Calcium Channel)IBA 01/2016
1	CytokinesIBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2013
1	omipalisibIBA 09/2013
1	dabrafenibIBA 09/2013
1	trametinibIBA 09/2013
1	Cisplatin (Platino)FDA LinkGeneric 06/2013
1	Antineoplastic Agents (Antineoplastics)IBA 06/2013
1	ProteomeIBA 06/2013
1	EnzymesIBA 06/2013
1	Singlet OxygenIBA 06/2013
1	RheniumIBA 06/2013
1	Inhibitor of Apoptosis ProteinsIBA 04/2013
1	birinapantIBA 04/2013
1	CaspasesIBA 04/2013
1	Retinoblastoma ProteinIBA 01/2013
1	dinaciclibIBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2013
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 09/2012
1	Oncogene Proteins (Oncogene Protein)IBA 06/2012
1	NaphtholsIBA 06/2012
1	Valine (L-Valine)FDA Link 06/2012
1	Glutamic Acid (Glutamate)FDA Link 06/2012
1	Mitogen-Activated Protein KinasesIBA 12/2011
1	Proto-Oncogene Proteins A-rafIBA 12/2010
1	EphA2 ReceptorIBA 11/2008
1	bosutinibIBA 05/2008
1	Imatinib Mesylate (Gleevec)FDA Link 04/2007
1	DNA (Deoxyribonucleic Acid)IBA 08/2005
1	Tyrosine (L-Tyrosine)FDA Link 08/2005
1	Urethane (Ethyl Carbamate)IBA 01/2003
1	Rifabutin (Ansamycin)FDA Link 03/2002
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2002

Therapy/Procedure

17	Therapeutics 11/2022 - 10/2010
3	Immunotherapy 11/2022 - 06/2013